Huaheng Biology announced that Ningbo Ruihe Yuan Venture Capital Partnership intends to transfer 3.3578 million shares through an inquiry price transfer method, accounting for 1.34% of Huaheng Biology's total share capital. This transfer will not be conducted through centralized bidding or block trading; the transferee will be institutional investors with appropriate pricing capabilities and risk-bearing abilities.
华恒生物：股东拟转让1.34%股份
Huaheng Biology: Shareholder plans to transfer 1.34% of shares.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated